{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:28:45Z","timestamp":1793921325094,"version":"4.8.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the treatment of most malignancies, radiotherapy plays a significant role. However, the resistance of cancer cells to ionizing radiation (IR) is the main reason for the failure of radiotherapy, which causes tumor recurrence and metastasis. In this study, we confirmed that GPR162, an orphan receptor in the G-protein-coupled receptor family, acted as a novel radiotherapy sensitizer by interacting with the stimulator of interferon genes (STING), which targeted DNA damage responses, activated IRF3, accelerated the activation of type I interferon system, promoted the expression of chemokines including CXCL10 and CXCL4, and inhibited the occurrence and development of tumors. Interestingly, the activation of STING by overexpression of GPR162 was independent of the classical pathway of cGAS. STING inhibitors could resist the antitumor effect of overexpression of GPR162 in IR-induced mouse models. In addition, most solid tumors showed low expression of GPR162. And the higher expression of GPR162 indicated a better prognosis in patients with lung adenocarcinoma, liver cancer, breast cancer, etc. In summary, these results suggested that GPR162 may serve as a potential sensitizer of radiotherapy by promoting radiotherapy-induced STING-IFN production and increasing the expression of chemokines including CXCL10 and CXCL4 in DNA damage response, providing an alternative strategy for improving cancer radiotherapy.<\/jats:p>","DOI":"10.1038\/s41392-022-01224-3","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T06:07:29Z","timestamp":1675231649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer"],"prefix":"10.1038","volume":"8","author":[{"given":"Yao","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0601-4991","authenticated-orcid":false,"given":"Xin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WeiWei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5162-3791","authenticated-orcid":false,"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4671-4896","authenticated-orcid":false,"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2204-5042","authenticated-orcid":false,"given":"Desheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-7277","authenticated-orcid":false,"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2354-5321","authenticated-orcid":false,"given":"Yongguang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"1224_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21689","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang, K. & Tepper, J. E. Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J. Clin. 71, 437\u2013454 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1224_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.molcel.2020.07.026","volume":"80","author":"T Reislander","year":"2020","unstructured":"Reislander, T., Groelly, F. J. & Tarsounas, M. DNA damage and cancer immunotherapy: a STING in the tale. Mol. Cell 80, 21\u201328 (2020).","journal-title":"Mol. Cell"},{"key":"1224_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41422-020-0346-1","volume":"30","author":"S Yum","year":"2020","unstructured":"Yum, S., Li, M. & Chen, Z. J. Old dogs, new trick: classic cancer therapies activate cGAS. Cell Res. 30, 639\u2013648 (2020).","journal-title":"Cell Res."},{"key":"1224_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.immuni.2018.07.008","volume":"49","author":"Y Hou","year":"2018","unstructured":"Hou, Y. et al. Non-canonical NF-kappaB antagonizes STING sensor-mediated DNA sensing in radiotherapy. Immunity 49, 490\u2013503.e494 (2018).","journal-title":"Immunity"},{"key":"1224_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","volume":"20","author":"M McLaughlin","year":"2020","unstructured":"McLaughlin, M. et al. Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat. Rev. Cancer 20, 203\u2013217 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1224_CR6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/2326-6066.CIR-17-0263","volume":"6","author":"BJ Francica","year":"2018","unstructured":"Francica, B. J. et al. TNFalpha and radioresistant stromal cells are essential for therapeutic efficacy of cyclic dinucleotide STING agonists in nonimmunogenic tumors. Cancer Immunol. Res. 6, 422\u2013433 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"1224_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ccell.2020.11.004","volume":"39","author":"J Guan","year":"2021","unstructured":"Guan, J. et al. MLH1 deficiency-triggered DNA hyperexcision by exonuclease 1 activates the cGAS-STING pathway. Cancer Cell 39, 109\u2013121.e105 (2021).","journal-title":"Cancer Cell"},{"key":"1224_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.immuni.2015.01.012","volume":"42","author":"A Hartlova","year":"2015","unstructured":"Hartlova, A. et al. DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity. Immunity 42, 332\u2013343 (2015).","journal-title":"Immunity"},{"key":"1224_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie, K. J. et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548, 461\u2013465 (2017).","journal-title":"Nature"},{"key":"1224_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41416-021-01543-2","volume":"126","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Lymphoid-specific helicase in epigenetics, DNA repair and cancer. Br. J. Cancer 126, 165\u2013173 (2021).","journal-title":"Br. J. Cancer"},{"key":"1224_CR11","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.7150\/thno.19988","volume":"7","author":"Y Jiang","year":"2017","unstructured":"Jiang, Y. et al. EGLN1\/c-Myc induced lymphoid-specific helicase inhibits ferroptosis through lipid metabolic gene expression changes. Theranostics 7, 3293\u20133305 (2017).","journal-title":"Theranostics"},{"key":"1224_CR12","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1158\/0008-5472.CAN-16-0268","volume":"76","author":"X He","year":"2016","unstructured":"He, X. et al. Chromatin remodeling factor LSH drives cancer progression by suppressing the activity of fumarate hydratase. Cancer Res. 76, 5743\u20135755 (2016).","journal-title":"Cancer Res."},{"key":"1224_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-016-0138-7","volume":"35","author":"S Liu","year":"2016","unstructured":"Liu, S. & Tao, Y. G. Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver. Chin. J. Cancer 35, 72 (2016).","journal-title":"Chin. J. Cancer"},{"key":"1224_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41422-018-0134-3","volume":"29","author":"Q Hu","year":"2019","unstructured":"Hu, Q. et al. LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. Cell Res. 29, 286\u2013304 (2019).","journal-title":"Cell Res."},{"key":"1224_CR15","doi-asserted-by":"publisher","first-page":"7133","DOI":"10.1038\/s41388-019-0909-0","volume":"38","author":"R Yang","year":"2019","unstructured":"Yang, R. et al. GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH. Oncogene 38, 7133\u20137145 (2019).","journal-title":"Oncogene"},{"key":"1224_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","volume":"5","author":"L Chen","year":"2020","unstructured":"Chen, L., Liu, S. & Tao, Y. Regulating tumor suppressor genes: post-translational modifications. Signal Transduct. Target Ther. 5, 90 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"1224_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0248-x","volume":"36","author":"Y Jiang","year":"2017","unstructured":"Jiang, Y., He, Y., Liu, S. & Tao, Y. Chromatin remodeling factor lymphoid-specific helicase inhibits ferroptosis through lipid metabolic genes in lung cancer progression. Chin. J. Cancer 36, 82 (2017).","journal-title":"Chin. J. Cancer"},{"key":"1224_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01157-x","volume":"19","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression. Mol. Cancer 19, 39 (2020).","journal-title":"Mol. Cancer"},{"key":"1224_CR19","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1158\/0008-5472.CAN-17-3454","volume":"78","author":"C Mao","year":"2018","unstructured":"Mao, C. et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53. Cancer Res. 78, 3484\u20133496 (2018).","journal-title":"Cancer Res."},{"key":"1224_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13072-019-0302-9","volume":"12","author":"L Chen","year":"2019","unstructured":"Chen, L. et al. DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism. Epigenet. Chromatin 12, 59 (2019).","journal-title":"Epigenet. Chromatin"},{"key":"1224_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ccell.2021.01.003","volume":"39","author":"M Ghosh","year":"2021","unstructured":"Ghosh, M. et al. Mutant p53 suppresses innate immune signaling to promote tumorigenesis. Cancer Cell 39, 494\u2013508e495 (2021).","journal-title":"Cancer Cell"},{"key":"1224_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2014.09.042","volume":"553","author":"V Caruso","year":"2014","unstructured":"Caruso, V. et al. The G protein-coupled receptor GPR162 is widely distributed in the CNS and highly expressed in the hypothalamus and in hedonic feeding areas. Gene 553, 1\u20136 (2014).","journal-title":"Gene"},{"key":"1224_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.gene.2016.01.044","volume":"581","author":"V Caruso","year":"2016","unstructured":"Caruso, V. et al. mRNA GPR162 changes are associated with decreased food intake in rat, and its human genetic variants with impairments in glucose homeostasis in two Swedish cohorts. Gene 581, 139\u2013145 (2016).","journal-title":"Gene"},{"key":"1224_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon, J. & Bakhoum, S. F. The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov. 10, 26\u201339 (2020).","journal-title":"Cancer Discov."},{"key":"1224_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ccell.2020.11.006","volume":"39","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity. Cancer Cell 39, 96\u2013108e106 (2021).","journal-title":"Cancer Cell"},{"key":"1224_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2089","volume":"3","author":"M Hesse","year":"2012","unstructured":"Hesse, M. et al. Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle. Nat. Commun. 3, 1076 (2012).","journal-title":"Nat. Commun."},{"key":"1224_CR27","doi-asserted-by":"publisher","first-page":"e1003368","DOI":"10.1371\/journal.pgen.1003368","volume":"9","author":"V Tripathi","year":"2013","unstructured":"Tripathi, V. et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 9, e1003368 (2013).","journal-title":"PLoS Genet."},{"key":"1224_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.radonc.2019.07.029","volume":"141","author":"J Marill","year":"2019","unstructured":"Marill, J., Mohamed Anesary, N. & Paris, S. DNA damage enhancement by radiotherapy-activated hafnium oxide nanoparticles improves cGAS-STING pathway activation in human colorectal cancer cells. Radiother. Oncol. 141, 262\u2013266 (2019).","journal-title":"Radiother. Oncol."},{"key":"1224_CR29","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.celrep.2019.09.050","volume":"29","author":"H Maekawa","year":"2019","unstructured":"Maekawa, H. et al. Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury. Cell Rep. 29, 1261\u20131273e1266 (2019).","journal-title":"Cell Rep."},{"key":"1224_CR30","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccell.2019.01.020","volume":"35","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. Inhibition of nuclear PTEN tyrosine phosphorylation enhances glioma radiation sensitivity through attenuated DNA repair. Cancer Cell 35, 504\u2013518e507 (2019).","journal-title":"Cancer Cell"},{"key":"1224_CR31","doi-asserted-by":"publisher","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","volume":"347","author":"S Liu","year":"2015","unstructured":"Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).","journal-title":"Science"},{"key":"1224_CR32","doi-asserted-by":"publisher","first-page":"E3403","DOI":"10.1073\/pnas.1603269113","volume":"113","author":"B Zhao","year":"2016","unstructured":"Zhao, B. et al. Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins. Proc. Natl Acad. Sci. USA 113, E3403\u2013E3412 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1224_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00262-009-0804-6","volume":"59","author":"D Savitsky","year":"2010","unstructured":"Savitsky, D., Tamura, T., Yanai, H. & Taniguchi, T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 59, 489\u2013510 (2010).","journal-title":"Cancer Immunol. Immunother."},{"key":"1224_CR34","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).","journal-title":"Science"},{"key":"1224_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","volume":"9","author":"T Sen","year":"2019","unstructured":"Sen, T. et al. Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer. Cancer Discov. 9, 646\u2013661 (2019).","journal-title":"Cancer Discov."},{"key":"1224_CR36","first-page":"60","volume":"382","author":"MD Mody","year":"2021","unstructured":"Mody, M. D. et al. Head and neck cancer. Lancet. 382, 60\u201372 (2021).","journal-title":"Lancet"},{"key":"1224_CR37","doi-asserted-by":"publisher","first-page":"eabd9882","DOI":"10.1126\/scitranslmed.abd9882","volume":"13","author":"J Murakami","year":"2021","unstructured":"Murakami, J. et al. Triple-modality therapy maximizes antitumor immune responses in a mouse model of mesothelioma. Sci.Transl. Med. 13, eabd9882 (2021).","journal-title":"Sci.Transl. Med"},{"key":"1224_CR38","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1158\/1078-0432.CCR-18-2581","volume":"25","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. The reciprocity between radiotherapy and cancer immunotherapy. Clin. Cancer Res. 25, 1709\u20131717 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1224_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrurol.2017.172","volume":"15","author":"RC Walshaw","year":"2018","unstructured":"Walshaw, R. C., Honeychurch, J., Illidge, T. M. & Choudhury, A. The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer. Nat. Rev. Urol. 15, 251\u2013259 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"1224_CR40","doi-asserted-by":"publisher","first-page":"104745","DOI":"10.1016\/j.phrs.2020.104745","volume":"155","author":"B Farhood","year":"2020","unstructured":"Farhood, B. et al. TGF-beta in radiotherapy: mechanisms of tumor resistance and normal tissues injury. Pharm. Res. 155, 104745 (2020).","journal-title":"Pharm. Res."},{"key":"1224_CR41","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1158\/1078-0432.CCR-17-0103","volume":"23","author":"V Saloura","year":"2017","unstructured":"Saloura, V. et al. Characterization of the T-cell receptor repertoire and immune microenvironment in patients with locoregionally advanced squamous cell carcinoma of the head and neck. Clin. Cancer Res. 23, 4897\u20134907 (2017).","journal-title":"Clin. Cancer Res."},{"key":"1224_CR42","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/SLA.0000000000002410","volume":"268","author":"RJ Kelly","year":"2018","unstructured":"Kelly, R. J. et al. The dynamic and transient immune microenvironment in locally advanced esophageal adenocarcinoma post chemoradiation. Ann. Surg. 268, 992\u2013999 (2018).","journal-title":"Ann. Surg."},{"key":"1224_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang, R. X. & Zhou, P. K. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct. Target Ther. 5, 60 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"1224_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.autrev.2008.12.002","volume":"8","author":"EY Lee","year":"2009","unstructured":"Lee, E. Y., Lee, Z. H. & Song, Y. W. CXCL10 and autoimmune diseases. Autoimmun. Rev. 8, 379\u2013383 (2009).","journal-title":"Autoimmun. Rev."},{"key":"1224_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga, R. et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat. Rev. 63, 40\u201347 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"1224_CR46","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/ijms22020843","volume":"22","author":"J Korbecki","year":"2021","unstructured":"Korbecki, J. et al. The effect of hypoxia on the expression of CXC chemokines and CXC chemokine receptors-a review of literature. Int. J. Mol. Sci. 22, 843 (2021).","journal-title":"Int. J. Mol. Sci"},{"key":"1224_CR47","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.3390\/cancers12113365","volume":"12","author":"T Jesenko","year":"2020","unstructured":"Jesenko, T. et al. Radiation induced upregulation of DNA sensing pathways is cell-type dependent and can mediate the off-target effects. Cancers 12, 3365 (2020).","journal-title":"Cancers"},{"key":"1224_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1152\/physiol.00022.2019","volume":"35","author":"B Briard","year":"2020","unstructured":"Briard, B., Place, D. E. & Kanneganti, T. D. DNA sensing in the innate immune response. Physiology 35, 112\u2013124 (2020).","journal-title":"Physiology"},{"key":"1224_CR49","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00018-017-2477-1","volume":"74","author":"L He","year":"2017","unstructured":"He, L. et al. Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis. Cell Mol. Life Sci. 74, 2395\u20132411 (2017).","journal-title":"Cell Mol. Life Sci."},{"key":"1224_CR50","doi-asserted-by":"publisher","first-page":"613039","DOI":"10.3389\/fimmu.2020.613039","volume":"11","author":"A Zahid","year":"2020","unstructured":"Zahid, A., Ismail, H., Li, B. & Jin, T. Molecular and structural basis of DNA sensors in antiviral innate immunity. Front. Immunol. 11, 613039 (2020).","journal-title":"Front. Immunol."},{"key":"1224_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/bs.apcsb.2018.11.004","volume":"115","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee, S. et al. Mechanistic link between DNA damage sensing, repairing and signaling factors and immune signaling. Adv. Protein Chem. Struct. Biol. 115, 297\u2013324 (2019).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"1224_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13238-021-00879-y","volume":"13","author":"X Li","year":"2021","unstructured":"Li, X. et al. cGAS guards against chromosome end-to-end fusions during mitosis and facilitates replicative senescence. Protein Cell. 13, 47\u201364 (2021).","journal-title":"Protein Cell"},{"key":"1224_CR53","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1038\/s41388-018-0224-1","volume":"37","author":"H Zhou","year":"2018","unstructured":"Zhou, H. et al. OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability. Oncogene 37, 3356\u20133368 (2018).","journal-title":"Oncogene"},{"key":"1224_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrd3320","volume":"10","author":"R Lappano","year":"2011","unstructured":"Lappano, R. & Maggiolini, M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov. 10, 47\u201360 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1224_CR55","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nm.4309","volume":"23","author":"J Chang","year":"2017","unstructured":"Chang, J. et al. Gpr124 is essential for blood-brain barrier integrity in central nervous system disease. Nat. Med. 23, 450\u2013460 (2017).","journal-title":"Nat. Med."},{"key":"1224_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26135-9","volume":"12","author":"Y Fujiwara","year":"2021","unstructured":"Fujiwara, Y. et al. The GPR171 pathway suppresses T cell activation and limits antitumor immunity. Nat. Commun. 12, 5857 (2021).","journal-title":"Nat. Commun."},{"key":"1224_CR57","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1158\/1078-0432.CCR-18-3382","volume":"25","author":"F Faiao-Flores","year":"2019","unstructured":"Faiao-Flores, F. et al. HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma. Clin. Cancer Res. 25, 5686\u20135701 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1224_CR58","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cell.2019.10.010","volume":"179","author":"SR Foster","year":"2019","unstructured":"Foster, S. R. et al. Discovery of human signaling systems: pairing peptides to G protein-coupled receptors. Cell 179, 895\u2013908.e821 (2019).","journal-title":"Cell"},{"key":"1224_CR59","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1038\/s41388-019-1151-5","volume":"39","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Cancer progression is mediated by proline catabolism in non-small cell lung cancer. Oncogene 39, 2358\u20132376 (2020).","journal-title":"Oncogene"},{"key":"1224_CR60","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-020-0181-3","volume":"5","author":"L Ouyang","year":"2020","unstructured":"Ouyang, L. et al. The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor. Signal Transduct. Target Ther. 5, 78 (2020).","journal-title":"Signal Transduct. Target Ther."}],"updated-by":[{"DOI":"10.1038\/s41392-023-01508-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000}}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01224-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01224-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01224-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T14:03:21Z","timestamp":1688133801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01224-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-01224-3","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41392-023-01508-2","asserted-by":"object"}]},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41392-023-01508-2","URL":"https:\/\/doi.org\/10.1038\/s41392-023-01508-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. Y.G.T. is a member of the editorial board, he has not been involved in the process of the manuscript handling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}